UK markets close in 48 minutes

Allied Biotech Corporation (1780.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
17.60-0.10 (-0.56%)
At close: 01:06PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 1.67B
Enterprise value 1.75B
Trailing P/E 17.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.34
Price/book (mrq)1.43
Enterprise value/revenue 2.42
Enterprise value/EBITDA 8.52

Trading information

Stock price history

Beta (5Y monthly) -0.02
52-week change 3-10.69%
S&P500 52-week change 323.57%
52-week high 319.85
52-week low 313.50
50-day moving average 317.49
200-day moving average 316.74

Share statistics

Avg vol (3-month) 375.48k
Avg vol (10-day) 336.46k
Shares outstanding 595.38M
Implied shares outstanding 697.56M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 46.82%
Trailing annual dividend rate 31.20
Trailing annual dividend yield 36.78%
5-year average dividend yield 44.02
Payout ratio 4118.81%
Dividend date 3N/A
Ex-dividend date 413 Jul 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 19.53%
Operating margin (ttm)13.42%

Management effectiveness

Return on assets (ttm)2.92%
Return on equity (ttm)12.92%

Income statement

Revenue (ttm)736.33M
Revenue per share (ttm)7.71
Quarterly revenue growth (yoy)5.40%
Gross profit (ttm)N/A
EBITDA 171.53M
Net income avi to common (ttm)143.79M
Diluted EPS (ttm)1.01
Quarterly earnings growth (yoy)-4.70%

Balance sheet

Total cash (mrq)841.02M
Total cash per share (mrq)8.82
Total debt (mrq)826.69M
Total debt/equity (mrq)73.20%
Current ratio (mrq)1.59
Book value per share (mrq)11.84

Cash flow statement

Operating cash flow (ttm)182.63M
Levered free cash flow (ttm)129.95M